Long-term follow-up of patients receiving injection therapy for erectile dysfunction

Urology

Volumn 49, Issue 6, 1997, Pages 932-935

  Sundaram, Chandru P ^a   Thomas, William ^a   Pryor, Laurie E ^a   Ami Sidi, A ^a   Billups, Kevin ^a   Pryor, Jon L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1;

ADULT; ARTICLE; FEAR; FOLLOW UP; HUMAN; INTRACAVERNOUS DRUG ADMINISTRATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT SATISFACTION; PENIS DISEASE; PENIS ERECTION; PRIORITY JOURNAL; QUESTIONNAIRE; SELF INJECTION; SEXUAL BEHAVIOR; SIDE EFFECT;

ADULT; FOLLOW-UP STUDIES; HUMANS; IMPOTENCE; INJECTIONS, SUBCUTANEOUS; MALE; MIDDLE AGED; PAPAVERINE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHENTOLAMINE; QUESTIONNAIRES; SELF ADMINISTRATION; TIME FACTORS; VASODILATOR AGENTS;

EID: 0030926568     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00079-4     Document Type: Article

References (9)

1. Brindley GS. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Br J Psychiatry. 143:1983;332-337.
2. Bennett AH, Carpenter AJ, Barada JH. An improved vasoactive drug combination for a pharmacological erection program. J Urol. 146:1991;1564-1565.
3. Sidi AA, Chen K-K. Clinical experience with vasoactive intracavernosal pharmacotherapy for treatment of impotence. World J Urol. 5:1987;156-159.
4. Levine SB, Althof SE, Turner LA, Risen CB, Bodner DR, Kursh ED, Resnick MI. Side effects of self-administration of intracavernous papaverine and phentolamine for the treatment of impotence. J Urol. 141:1989;54-57.
5. Lakin MM, Montague DK, Medendorp SV, Tesar L, Schover LR. Intracavernous injection therapy: analysis of results and complications. J Urol. 143:1990;1138-1141.
6. Hollander JB, Gonzalez J, Norman T. Patient satisfaction with pharmacologic erection program. Urology. 39:1992;439-441.
7. Virag R, Shoukry K, Floresco J, Nollet F, Greco E. Intracavernous self-injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases. J Urol. 145:1991;287-293.
8. Montorsi F, Guazzoni G, Bergamaschi F, Ferini-Strambi L, Barbieri L, Rigatti P. Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction. J Urol. 149:1993;1291-1295.
9. Girdley FM, Bruskewitz RC, Feyzi J, Graversen PH, Gasser TC. Intracavernous self-injection for impotence: a long-term therapeutic option? Experience in 78 patients. J Urol. 140:1988;972-974.